THE CB1 CANNABINOID RECEPTOR ANTAGONIST SR 141716A AFFECTS A(9) DOPAMINE NEURONAL-ACTIVITY IN THE RAT

被引:36
作者
GUEUDET, C [1 ]
SANTUCCI, V [1 ]
RINALDICARMONA, M [1 ]
SOUBRIE, P [1 ]
LEFUR, G [1 ]
机构
[1] SANOFI RECH,DEPT NEUROPSYCHIAT,F-34184 MONTPELLIER 04,FRANCE
关键词
CB1; RECEPTOR; SR; 141716A; DOPAMINE NEURONS; APOMORPHINE; AMPHETAMINE;
D O I
10.1097/00001756-199507100-00015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
CB1 receptors and their putative natural ligand anandamide, have been tentatively involved in the control of midbrain extrapyramidal function. Electrophysiological activity of dopamine neurones was measured after acute and repeated administration of the CB1 receptor antagonist SR 141716A (0.3-3 mg kg(-1)) in rats. Acute SR 141716A increased A(9), but not A(10) cell population response without affecting either their spontaneous firing rate or apomorphine-induced rate inhibition and prevented amphetamine-induced inhibition of A(9), but not of A(10) cell firing. After repeated administration SR 141716A (1 or 5 mg kg(-1)) decreased population response of A(9) cells, which was reversed by apomorphine. These results suggest that CB1 receptor blockade by SR 141716A interrupts a cannabinoid-like endogenous tone controlling extrapyramidal function.
引用
收藏
页码:1421 / 1425
页数:5
相关论文
共 25 条
  • [1] CANNABINOID RECEPTORS AND MODULATION OF CYCLIC-AMP ACCUMULATION IN THE RAT-BRAIN
    BIDAUTRUSSELL, M
    DEVANE, WA
    HOWLETT, AC
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 55 (01) : 21 - 26
  • [2] ACUTE AND CHRONIC HALOPERIDOL TREATMENT - COMPARISON OF EFFECTS ON NIGRAL DOPAMINERGIC CELL ACTIVITY
    BUNNEY, BS
    GRACE, AA
    [J]. LIFE SCIENCES, 1978, 23 (16) : 1715 - 1727
  • [3] D-AMPHETAMINE-INDUCED DEPRESSION OF CENTRAL DOPAMINE NEURONS - EVIDENCE FOR MEDIATION BY BOTH AUTORECEPTORS AND A STRIATO-NIGRAL FEEDBACK PATHWAY
    BUNNEY, BS
    AGHAJANIAN, GK
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1978, 304 (03) : 255 - 261
  • [4] MIDBRAIN DOPAMINE SYSTEM ELECTROPHYSIOLOGICAL FUNCTIONING - A REVIEW AND NEW HYPOTHESIS
    BUNNEY, BS
    CHIODO, LA
    GRACE, AA
    [J]. SYNAPSE, 1991, 9 (02) : 79 - 94
  • [5] DEVANE WA, 1988, MOL PHARMACOL, V34, P605
  • [6] ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR
    DEVANE, WA
    HANUS, L
    BREUER, A
    PERTWEE, RG
    STEVENSON, LA
    GRIFFIN, G
    GIBSON, D
    MANDELBAUM, A
    ETINGER, A
    MECHOULAM, R
    [J]. SCIENCE, 1992, 258 (5090) : 1946 - 1949
  • [7] FORMATION AND INACTIVATION OF ENDOGENOUS CANNABINOID ANANDAMIDE IN CENTRAL NEURONS
    DIMARZO, V
    FONTANA, A
    CADAS, H
    SCHINELLI, S
    CIMINO, G
    SCHWARTZ, JC
    PIOMELLI, D
    [J]. NATURE, 1994, 372 (6507) : 686 - 691
  • [8] LOSS OF CANNABINOID RECEPTORS IN THE SUBSTANTIA-NIGRA IN HUNTINGTONS-DISEASE
    GLASS, M
    FAULL, RLM
    DRAGUNOW, M
    [J]. NEUROSCIENCE, 1993, 56 (03) : 523 - 527
  • [9] SPONTANEOUS ACTIVITY OF A9-DOPAMINE AND A10-DOPAMINE NEURONS AFTER ACUTE AND CHRONIC ADMINISTRATION OF THE SELECTIVE DOPAMINE D-1-RECEPTOR ANTAGONIST SCH 23390
    GOLDSTEIN, JM
    LITWIN, LC
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (1-2) : 175 - 180
  • [10] GOLDSTEIN JM, 1989, J PHARMACOL EXP THER, V249, P673